The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome

BACKGROUND: Drug induced liver injury (DILI) is a rising morbidity amongst patients with COVID-19 clinical syndrome. The updated RUCAM causality assessment scale is validated for use in the general population, but its utility for causality determination in cohorts of patients with COVID-19 and DILI...

Descripción completa

Detalles Bibliográficos
Autores principales: Naseralallah, Lina Mohammad, Aboujabal, Bodoor Abdallah, Geryo, Nejat Mohamed, Al Boinin, Aisha, Al Hattab, Fatima, Akbar, Raza, Umer, Waseem, Abdul Jabbar, Layla, Danjuma, Mohammed I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436150/
https://www.ncbi.nlm.nih.gov/pubmed/36048762
http://dx.doi.org/10.1371/journal.pone.0268705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436150/
https://www.ncbi.nlm.nih.gov/pubmed/36048762
http://dx.doi.org/10.1371/journal.pone.0268705

Ejemplares similares